Welcome to the GHAPP Digital Hub

The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). The GHAPP Digital Hub is the place for all GI & Liver digital education for APPs. Here you will have access to podcasts and various short video modules.

Faculty

Kate Scarlata

MPH, RD

Medway, Massachusetts

Daksesh Patel

D.O

St. Francis Hospital

Kaitlin Colella

PA

Orlando Health Digestive Health Institute

Andrea Gossard

APRN, CNP

Rochester, MN

Lindsay Yoder

MPAS, PA-C

Indianapolis, Indiana

Lucy Mathew

NP, MSN

Los Angeles, California

Allison Moser

FNP-BC

Chicago, IL

Jeremy Davis

ACNP

Shreveport, LA

Jordan Mayberry

PA-C

UT Southwestern Medical Center

Renee Pozza

NP

San Diego, CA

Allysa Sagese

NP

New York, New York

Robin Soto

NP

UC San Diego Health

April Morris

FNP

Liver Institute of Virginia

Patrick Horne

NP

University of Florida

Whitney Steinmetz

NP

Presbyterian Healthcare Services

Jonathan Yeh

PA

Columbia University Irving Medical Center

Lisa Richards

NP

UC San Diego

Corrie Berk

NP

The Texas Liver Institute

Kimberly Kearns

NP-C

DuPage Medical Group

Kimberly Orleck

PA-C

Atlanta Gastroenterology Associates

Podcasts

GHAPPcast - CSID in Adults: Clinical Pearls & the Patient Journey

GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024

GHAPP PBC Podcast Series Part 2: New Therapeutics In The PBC Space

GHAPP PBC Podcast Series Part 1: Prevalence, Awareness and Identification of PBC

KOL Conversation: A New Treatment Option

KOL Conversation: New & Emerging Treatment Considerations for PBC & PBC Pruritus

Recognizing the Severity of MASH

Navigating IBS: Pathophysiology, Neuromodulators, and Patient-Centered Care

GHAPP/CLDF Podcast: Cirrhosis and Hepatic Encephalopathy

Biosimilars and the Patient Perspective

Mastering IBS-C: Diagnostic Strategies, Differentiation, and Management.

Biosimilars Unveiled: Empowering APPs for Better Patient Conversations

Webcasts

Defining, Diagnosing, & Treating MASH

Lifestyle Modifications for Patients With MASH

Treatment of Metabolic Disorders and the Role of APPs in MASH

Updates On Approved Treatments for MASH

MASH Bootcamp Q&A

Identifying & Diagnosing MASH Patients with Non-Invasive Tests

2024 IBD Bootcamp

PBC New Therapeutic

FAQ Video Modules

How is MASH severity staged? What would an ideal MASH NIT algorithm look like?

What are the consequences of MASH going untreated?

What is MASH?

What does it mean for a biosimilar to be interchangeable and why is that important?

What resources do you use to understand the latest approaches to managing IBS-C patients?

Best practices to accelerate the time to finding the right therapy for your patients with IBS-C?

Best practices in determining clinically meaningful “response” to therapy for IBS-C patients?

What is the Difference Between Biosimilars and Generics?

What role does a new mechanism of action play in your prescribing decisions of IBS-C therapy?

Download the app and start using it now.

Download on the App Store

GET IT ON Google Play

Journal Club Video Modules

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Medication Review Video Modules

What is Resmetirom and how does it work to treat MASH?

What is the clinical profile of Resmetirom, including dosing schedules?